Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HY-07170702
- Development stage
- Phase 1
- Lead developer
- Hefei Medical and Pharmaceutical
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
HY-07170702 is a small molecule drug developed as a topical ointment for dermatological use. It is currently under investigation for the treatment of atopic dermatitis, with its primary therapeutic focus on immune system diseases, congenital disorders, and skin and musculoskeletal diseases. The drug has reached IND (Investigational New Drug) approval status in China but has not yet advanced beyond early clinical development. Its precise mechanism of action and molecular targets have not been publicly disclosed[1][2].
Beyond the preview
Go deeper on HY-07170702.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HY-07170702.